Presentation Information

[LS1]Evolving Personalized Medicine for Breast Cancer: Expectations for PARP Inhibitors

Takanori Ishida (Departments of Breast and Endocrine Surgical Oncology, Tohoku University Graduate School of Medicine)

Login required to view

Login is required to view some content.